SCHEMBL8974181

SCHEMBL8974181

NS(=O)(=O)c1ccc(C2=CC(CF)C=C2c2ccc(C(F)(F)F)cn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.48
CHRNA7 P36544 2/20 0.43
PTGS2 P35354 8/20 0.41
PTGS1 P23219 3/20 0.41
CYP2C9 P11712 1/20 0.38
PDPK1 O15530 1/20 0.38
CA2 P00918 5/20 0.37
CA12 O43570 4/20 0.37
CA1 P00915 4/20 0.37
CA9 Q16790 4/20 0.37
GCK P35557 1/20 0.36
GCKR Q14397 1/20 0.36
MAPT P10636 1/20 0.36
TRPA1 O75762 1/20 0.36
CA4 P22748 2/20 0.36
CA7 P43166 2/20 0.36
TRPV1 Q8NER1 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974228 0.93 KIF11 (0.48) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974646 0.90 KIF11 (0.47) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974206 0.90 KIF11 (0.47) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974330 0.89 PTGS2 (0.45) KIF11PTGS2PTGS1
SCHEMBL8974597 0.87 KIF11 (0.52) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974079 0.87 KIF11 (0.64) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974487 0.86 KIF11 (0.50) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974232 0.86 KIF11 (0.50) KIF11CHRNA7PTGS2PTGS1CYP2C9
SCHEMBL8974183 0.85 CA2 (0.41) CHRNA7PTGS2PTGS1CA2CA12
SCHEMBL8973758 0.84 PTGS2 (0.41) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed